{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:42:46Z","timestamp":1792806166315,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","award":["22230551"],"award-info":[{"award-number":["22230551"]}],"id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.diabres.2026.113433","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:59:44Z","timestamp":1783954784000},"page":"113433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Healthcare cost trajectories before and after incident cardiovascular disease in type 2 diabetes: A latent class analysis"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3026-357X","authenticated-orcid":false,"given":"Minglu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanrong","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby Q.Y.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1581-5643","authenticated-orcid":false,"given":"Eric S.H.","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2193-1114","authenticated-orcid":false,"given":"Hongjiang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8927-6764","authenticated-orcid":false,"given":"Alice P.S.","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea O.Y.","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1227-803X","authenticated-orcid":false,"given":"Ronald C.W.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun Kwan","family":"O","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6214-6924","authenticated-orcid":false,"given":"Lee-Ling","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny Y.Z.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5158-2245","authenticated-orcid":false,"given":"Weijian","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C.N.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4034-1286","authenticated-orcid":false,"given":"Juliana N.M.","family":"Lui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10397","key":"10.1016\/j.diabres.2026.113433_b0005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the GBD Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.diabres.2026.113433_b0010","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41574-022-00690-7","article-title":"The burden and risks of emerging complications of diabetes mellitus","volume":"18","author":"Tomic","year":"2022","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.diabres.2026.113433_b0015","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14970","article-title":"Incremental healthcare costs attributable to type 2 diabetes in Hong Kong: a population-based cost of illness study","volume":"40","author":"Quan","year":"2023","journal-title":"Diabet Med"},{"issue":"2","key":"10.1016\/j.diabres.2026.113433_b0020","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.diabres.2014.03.020","article-title":"Cost-of-illness studies of diabetes mellitus: a systematic review","volume":"105","author":"Ng","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2026.113433_b0025","unstructured":"Magliano DJ, Boyko EJ, International Diabetes Federation (IDF) Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas 10th edition. 2021."},{"key":"10.1016\/j.diabres.2026.113433_b0030","series-title":"Diabetes in America: National Institute of Diabetes and Digestive and Kidney Diseases (US)","article-title":"Health care utilization and costs of diabetes","author":"McEwen","year":"2018"},{"key":"10.1016\/j.diabres.2026.113433_b0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111961","article-title":"Temporal incremental healthcare costs associated with complications in Hong Kong Chinese patients with type 2 diabetes: a prospective study in Joint Asia diabetes evaluation (JADE) Register (2007-2019)","volume":"219","author":"Lui","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"10.1016\/j.diabres.2026.113433_b0040","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/dme.12647","article-title":"The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84)","volume":"32","author":"Alva","year":"2015","journal-title":"Diabet Med"},{"issue":"1","key":"10.1016\/j.diabres.2026.113433_b0045","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/dci23-0085","article-title":"Economic costs of diabetes in the U.S. in 2022","volume":"47","author":"Parker","year":"2024","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.diabres.2026.113433_b0050","article-title":"Trends in cardiovascular diseases and costs among type 2 diabetes mellitus (T2DM) patients in Malaysia: a cohort study of 240,611 public hospital inpatients","volume":"16","author":"Kamarudin","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.diabres.2026.113433_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2023.104959","article-title":"Association between multimorbidity patterns and healthcare costs among middle-aged and older adults in China","volume":"109","author":"Zhao","year":"2023","journal-title":"Arch Gerontol Geriatr"},{"issue":"6","key":"10.1016\/j.diabres.2026.113433_b0060","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1007\/s40273-023-01258-7","article-title":"Projecting the health and economic burden of cardiovascular disease among people with type 2 diabetes, 2022-2031","volume":"41","author":"Abushanab","year":"2023","journal-title":"Pharmacoeconomics"},{"issue":"10","key":"10.1016\/j.diabres.2026.113433_b0065","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1056\/NEJMp1608511","article-title":"Caring for high-need, high-cost patients - an urgent priority","volume":"375","author":"Blumenthal","year":"2016","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2026.113433_b0070","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.2105\/AJPH.2004.059204","article-title":"Causation and causal inference in epidemiology","volume":"95","author":"Rothman","year":"2005","journal-title":"Am J Public Health"},{"key":"10.1016\/j.diabres.2026.113433_b0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0095798420930932","article-title":"Latent class analysis: a guide to best practice","volume":"46","author":"Weller","year":"2020","journal-title":"J Black Psychol"},{"issue":"6","key":"10.1016\/j.diabres.2026.113433_b0080","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1530-0277.2000.tb02070.x","article-title":"Integrating person-centered and variable-centered analyses: growth mixture modeling with latent trajectory classes","volume":"24","author":"Muth\u00e9n","year":"2000","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.diabres.2026.113433_b0085","unstructured":"Magidson J, Vermunt JK. A nontechnical introduction to latent class models. Statistical Innovations white paper. 2002;1:15."},{"issue":"7","key":"10.1016\/j.diabres.2026.113433_b0090","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jama.2020.2278","article-title":"Using latent class analysis to identify hidden clinical phenotypes","volume":"324","author":"Mori","year":"2020","journal-title":"J Am Med Assoc"},{"issue":"11","key":"10.1016\/j.diabres.2026.113433_b0095","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1111\/dom.15768","article-title":"Cardiovascular phenotypes in type 2 diabetes: latent class analysis of the CANVAS Program and CREDENCE trial","volume":"26","author":"Razaghizad","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.diabres.2026.113433_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108742","article-title":"Applying latent class analysis to risk stratification of incident diabetes among Chinese adults","volume":"174","author":"Wu","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2026.113433_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112037","article-title":"Psychosocial and behavioral risk patterns and risk of cardiovascular complications in people with type 2 diabetes","volume":"221","author":"Wu","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"10.1016\/j.diabres.2026.113433_b0110","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.2337\/dci19-0003","article-title":"From Hong Kong diabetes register to JADE program to RAMP-DM for data-driven actions","volume":"42","author":"Chan","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.diabres.2026.113433_b0115","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"issue":"7875","key":"10.1016\/j.diabres.2026.113433_b0120","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/d41586-021-02401-0","article-title":"Personalized profiles for disease risk must capture all facets of health","volume":"597","author":"McCarthy","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.diabres.2026.113433_b0125","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41591-024-03032-4","article-title":"A global initiative to deliver precision health in diabetes","volume":"30","author":"Cefalu","year":"2024","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.diabres.2026.113433_b0130","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"10.1016\/j.diabres.2026.113433_b0135","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jchf.2021.03.003","article-title":"Patient phenotypes and SGLT-2 inhibition in type 2 diabetes: insights from the EMPA-REG OUTCOME Trial","volume":"9","author":"Sharma","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"1","key":"10.1016\/j.diabres.2026.113433_b0140","doi-asserted-by":"crossref","first-page":"204","DOI":"10.2337\/dc20-2806","article-title":"Cluster analysis of cardiovascular phenotypes in patients with type 2 diabetes and established atherosclerotic cardiovascular disease: a potential approach to precision medicine","volume":"45","author":"Sharma","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2026.113433_b0145","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc17-1763","article-title":"Health care costs associated with incident complications in patients with type 2 diabetes in Germany","volume":"41","author":"K\u00e4hm","year":"2018","journal-title":"Diabetes Care"},{"issue":"10267","key":"10.1016\/j.diabres.2026.113433_b0150","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.diabres.2026.113433_b0155","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/dc19-0573","article-title":"The association between poor glycemic control and health care costs in people with diabetes: a population-based study","volume":"43","author":"Mata-Cases","year":"2020","journal-title":"Diabetes Care"},{"issue":"10","key":"10.1016\/j.diabres.2026.113433_b0160","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70014","article-title":"Overview of oxidative stress and inflammation in diabetes","volume":"16","author":"Weinberg Sibony","year":"2024","journal-title":"J Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2026.113433_b0165","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-024-06254-w","article-title":"Glycaemic control is still central in the hierarchy of priorities in type 2 diabetes management","volume":"68","author":"Khunti","year":"2025","journal-title":"Diabetologia"},{"issue":"9933","key":"10.1016\/j.diabres.2026.113433_b0170","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(14)60040-4","article-title":"Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes","volume":"383","author":"Peters","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.diabres.2026.113433_b0175","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/s00125-019-4926-x","article-title":"Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals","volume":"62","author":"Ohkuma","year":"2019","journal-title":"Diabetologia"},{"issue":"24","key":"10.1016\/j.diabres.2026.113433_b0180","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1161\/CIRCULATIONAHA.118.039100","article-title":"Cardiovascular risk and risk factor management in type 2 diabetes mellitus: a population-based cohort study assessing sex disparities","volume":"139","author":"Wright","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.diabres.2026.113433_b0185","article-title":"Gender-associated cardiometabolic risk profiles and health behaviors in patients with type 2 diabetes: a cross-sectional analysis of the Joint Asia Diabetes Evaluation (JADE) program","volume":"32","author":"Lim","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"12","key":"10.1016\/j.diabres.2026.113433_b0190","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2337\/dc08-0985","article-title":"Depression and type 2 diabetes over the lifespan: a meta-analysis","volume":"31","author":"Mezuk","year":"2008","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2026.113433_b0195","first-page":"837","article-title":"Depression as a risk factor for the onset of type 2 diabetes mellitus","volume":"49","author":"Knol","year":"2006","journal-title":"A meta-analysis Diabetologia"},{"issue":"12","key":"10.1016\/j.diabres.2026.113433_b0200","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1007\/s00125-010-1874-x","article-title":"Type 2 diabetes mellitus as a risk factor for the onset of depression: a systematic review and meta-analysis","volume":"53","author":"Nouwen","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabres.2026.113433_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2024.1284799","article-title":"Associations of comorbid depression with cardiovascular-renal events and all-cause mortality accounting for patient reported outcomes in individuals with type 2 diabetes: a 6-year prospective analysis of the Hong Kong Diabetes Register","volume":"15","author":"Yeung","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"10.1016\/j.diabres.2026.113433_b0210","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jama.2014.8040","article-title":"The mental health comorbidities of diabetes","volume":"312","author":"Ducat","year":"2014","journal-title":"J Am Med Assoc"},{"issue":"3","key":"10.1016\/j.diabres.2026.113433_b0215","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/M18-1900","article-title":"Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: a population-based cohort study","volume":"170","author":"Ke","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2026.113433_b0220","doi-asserted-by":"crossref","unstructured":"Wu H., Zhou H., Huang C., Yang A., Lau E.S.H., Zhang X., et al. Population-level productivity-adjusted life years lost in individuals with type 2 diabetes in Hong Kong: a life table modelling study. Lancet Reg Health West Pac. 2025;59:101585.","DOI":"10.1016\/j.lanwpc.2025.101585"},{"issue":"9","key":"10.1016\/j.diabres.2026.113433_b0225","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.2337\/dc13-2484","article-title":"The lifetime cost of diabetes and its implications for diabetes prevention","volume":"37","author":"Zhuo","year":"2014","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2026.113433_b0230","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa2100165","article-title":"Long-term complications in youth-onset type 2 diabetes","volume":"385","author":"Bjornstad","year":"2021","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.diabres.2026.113433_b0235","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S2213-8587(24)00242-0","article-title":"Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK prospective diabetes study (UKPDS) with up to 30 years of follow-up (UKPDS 92)","volume":"12","author":"Lin","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.diabres.2026.113433_b0240","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ncpneph0378","article-title":"Anemia in diabetes: marker or mediator of microvascular disease?","volume":"3","author":"Thomas","year":"2007","journal-title":"Nat Clin Pract Nephrol"},{"key":"10.1016\/j.diabres.2026.113433_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8745968","article-title":"Clinical implications of the coexistence of anemia and diabetes mellitus in the elderly population","volume":"2021","author":"Michalak","year":"2021","journal-title":"J Diabetes Res"},{"issue":"Suppl 1","key":"10.1016\/j.diabres.2026.113433_b0250","doi-asserted-by":"crossref","first-page":"i56","DOI":"10.1093\/eurpub\/ckac074","article-title":"Economic evaluation of physical activity interventions for type 2 diabetes management: a systematic review","volume":"32","author":"Barbosa","year":"2022","journal-title":"Eur J Pub Health"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822726003530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T01:16:00Z","timestamp":1792804560000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822726003530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":50,"alternative-id":["S0168822726003530"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113433","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Healthcare cost trajectories before and after incident cardiovascular disease in type 2 diabetes: A latent class analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2026.113433","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"113433"}}